The Role of Virtual Reality in the Management of Irritable Bowel Syndrome.

Q1 Medicine

Current Gastroenterology Reports Pub Date : 2024-11-01 Epub Date: 2024-08-13 DOI:10.1007/s11894-024-00940-w

Karisma K Suchak, Christopher V Almario, Omer Liran, Robert Chernoff, Brennan R Spiegel

{"title":"The Role of Virtual Reality in the Management of Irritable Bowel Syndrome.","authors":"Karisma K Suchak, Christopher V Almario, Omer Liran, Robert Chernoff, Brennan R Spiegel","doi":"10.1007/s11894-024-00940-w","DOIUrl":null,"url":null,"abstract":"Purpose of review: Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction that significantly impacts health-related quality of life (HRQOL). This article explores the potential role of virtual reality (VR)-based cognitive behavioral therapy (CBT) in treating patients with IBS.Recent findings: While CBT is a proven, skills-based therapy approach that modifies behaviors and alters dysfunctional thinking patterns to influence the gut-brain axis and improve IBS symptoms, it is rarely prescribed given a paucity of CBT-trained clinicians. We developed a novel VR program that delivers a standardized CBT program over an 8-week period to help patients manage their symptoms. In initial qualitative validation testing, patients expressed positive perceptions about using VR CBT for IBS. Home-based, standardized VR CBT has the potential to be an effective and scalable treatment option for patients with IBS. While initial studies have shown proof-of-concept definitive randomized controlled trials are needed to demonstrate the efficacy of self-administered VR CBT in IBS.","PeriodicalId":10776,"journal":{"name":"Current Gastroenterology Reports","volume":" ","pages":"294-303"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11401788/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Gastroenterology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s11894-024-00940-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/13 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction that significantly impacts health-related quality of life (HRQOL). This article explores the potential role of virtual reality (VR)-based cognitive behavioral therapy (CBT) in treating patients with IBS.

Recent findings: While CBT is a proven, skills-based therapy approach that modifies behaviors and alters dysfunctional thinking patterns to influence the gut-brain axis and improve IBS symptoms, it is rarely prescribed given a paucity of CBT-trained clinicians. We developed a novel VR program that delivers a standardized CBT program over an 8-week period to help patients manage their symptoms. In initial qualitative validation testing, patients expressed positive perceptions about using VR CBT for IBS. Home-based, standardized VR CBT has the potential to be an effective and scalable treatment option for patients with IBS. While initial studies have shown proof-of-concept definitive randomized controlled trials are needed to demonstrate the efficacy of self-administered VR CBT in IBS.

查看原文本刊更多论文

虚拟现实技术在肠易激综合征治疗中的作用。

综述的目的：肠易激综合征（IBS）是一种肠道与大脑相互作用的疾病，严重影响与健康相关的生活质量（HRQOL）。本文探讨了基于虚拟现实（VR）的认知行为疗法（CBT）在治疗肠易激综合征患者中的潜在作用：虽然 CBT 是一种行之有效的、以技能为基础的治疗方法，它能改变行为，改变功能失调的思维模式，从而影响肠道-大脑轴，改善肠易激综合征症状，但由于受过 CBT 培训的临床医生很少，因此很少有人采用这种方法。我们开发了一种新颖的 VR 程序，在 8 周内提供标准化的 CBT 程序，帮助患者控制症状。在最初的定性验证测试中，患者对使用 VR CBT 治疗肠易激综合征表达了积极的看法。基于家庭的标准化 VR CBT 有可能成为肠易激综合征患者有效且可扩展的治疗方案。虽然初步研究已经证明了这一概念，但要证明自控式 VR CBT 对肠易激综合征的疗效，还需要进行明确的随机对照试验。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Gastroenterology Reports Medicine-Gastroenterology

CiteScore

7.80

自引率

0.00%

发文量

期刊介绍： As the field of gastroenterology and hepatology rapidly evolves, the wealth of published literature can be overwhelming. The aim of the journal is to help readers stay abreast of such advances by offering authoritative, systematic reviews by leading experts. We accomplish this aim by appointing Section Editors who invite international experts to contribute review articles that highlight recent developments and important papers published in the past year. Major topics in gastroenterology are covered, including pediatric gastroenterology, neuromuscular disorders, infections, nutrition, and inflammatory bowel disease. These reviews provide clear, insightful summaries of expert perspectives relevant to clinical practice. An Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research. We also provide commentaries from well-known figures in the field.